Point-of-Care Focus HemoCue specializes in point-of-care diagnostics for hemoglobin, glucose, HbA1c, and white blood cell counts, presenting clear opportunities to upsell integrated POCT solutions and repository workflows in clinical settings.

Healthcare Partnerships As part of Danaher, HemoCue highlights access to a broader science and technology ecosystem, suggesting co-selling or integration opportunities with other Danaher brands to expand market reach and bundled offerings.

Strategic Events Regular participation in global health and transfusion medicine events (AABB, World Health Assembly, ISBT Congress) indicates a strong channel for live demos, customer outreach, and thought leadership to generate leads and accelerate adoption.

Markets & Revenue Current revenue range indicates a mid-market niche with lean operations; targeting hospital systems, regional blood banks, and specialty clinics with scalable POCT panels could drive higher volume sales and cross-sell opportunities across hematology and biochemistry tests.

Product Ecosystem The portfolio covers essentialPOCT tests; explore opportunities for expanding WBC differential, HbA1c, and glucose testing with integrated data capture, LIS/HIS connectivity, and remote monitoring to appeal to facilities seeking streamlined workflows.